We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$622M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$597M
3
CMCSA icon
Comcast
CMCSA
+$461M
4
UNH icon
UnitedHealth
UNH
+$409M
5
MXIM
Maxim Integrated Products
MXIM
+$343M

Sector Composition

Rank Sector Weight
1 Technology 3.08%
2 Consumer Discretionary 2.25%
3 Financials 2.23%
4 Healthcare 2.22%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CREG
13776
DELISTED
Smart Powerr
CREG
– –
-158
Closed -$144K
CRTO icon
13777
Criteo S.A. Ordinary Shares
CRTO
$945M
– –
-73,010
Closed -$2.81M
CRVL icon
13778
CorVel
CRVL
$3.3B
– –
-4,833
Closed -$216K
CRVS icon
13779
Corvus Pharmaceuticals
CRVS
$1.24B
– –
-29,278
Closed -$86.7K
CSGP icon
13780
CoStar Group
CSGP
$13.1B
– –
-657,599
Closed -$56.8M
CTMX icon
13781
CytomX Therapeutics
CTMX
$736M
– –
-769,766
Closed -$4.12M
CTSO icon
13782
CALL
Cytosorbents Corp
CTSO
$24.8M
– –
-27,500
Closed -$208K
CUE icon
13783
Cue Biopharma
CUE
$139M
– –
-725
Closed -$253K
CUK
13784
PUT
DELISTED
Carnival PLC
CUK
– –
-14,800
Closed -$344K
CURI icon
13785
CuriosityStream
CURI
$219M
– –
-196,656
Closed -$2.31M
CVEO icon
13786
PUT
Civeo
CVEO
$343M
– –
-10,300
Closed -$183K
CVLG icon
13787
PUT
Covenant Logistics
CVLG
$888M
– –
-31,400
Closed -$325K
CVRX icon
13788
CVRx
CVRX
$83.4M
– –
-62,514
Closed -$1.75M
CVV icon
13789
CVD Equipment Corp
CVV
$54.4M
– –
-14,352
Closed -$65K
CW icon
13790
Curtiss-Wright
CW
$25.7B
– –
-43,109
Closed -$5.15M
CWBC
13791
Community West Bancshares
CWBC
$705M
– –
-16,552
Closed -$333K
CWCO icon
13792
Consolidated Water Co
CWCO
$498M
– –
-18,777
Closed -$226K
CWEN icon
13793
Clearway Energy Class C
CWEN
$7.03B
– –
-28,117
Closed -$837K
CWEN.A
13794
DELISTED
Clearway Energy Class A
CWEN.A
– –
-37,460
Closed -$1.05M
CWT icon
13795
California Water Service
CWT
$3.1B
– –
-3,839
Closed -$236K
DALN
13796
DELISTED
DallasNews
DALN
– –
-14,049
Closed -$105K
DAO
13797
Youdao
DAO
$2.16B
– –
-10,288
Closed -$140K
DBC icon
13798
Invesco DB Commodity Index Tracking Fund
DBC
$1.73B
– –
-29,872
Closed -$573K
DBVT
13799
CALL
DBV Technologies
DBVT
$872M
– –
-3,310
Closed -$181K
DBVT
13800
PUT
DBV Technologies
DBVT
$872M
– –
-1,000
Closed -$55K
550 551
552
553 554

Similar funds

Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Ken Griffin's Q3 2021 Portfolio in Review

As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.